Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96

Gynecologic Oncology

Volumn 132, Issue 1, 2014, Pages 203-210

  Fauci, Janelle M ^a   Sabbatino, Francesco ^b   Wang, Yangyang ^b   Londoño Joshi, Angelina I ^c   Straughn, J Michael ^a   Landen, Charles N ^a   Ferrone, Soldano ^b   Buchsbaum, Donald J ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c University of Alabama at Birmingham   (United States)

^d The University of Alabama at Birmingham   (United States)

Author keywords

B7 H3; Cancer initiating cells; Chemoresistance; Immunotherapy; Ovarian cancer; Sunitinib

Indexed keywords

B7 H3 EPITOPE; CARBOPLATIN; DOCETAXEL; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 376.96; PACLITAXEL; SUNITINIB; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CARCINOMA CELL; CELL DIFFERENTIATION; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL LINE;

B7-H3; CANCER INITIATING CELLS; CHEMORESISTANCE; IMMUNOTHERAPY; OVARIAN CANCER; SUNITINIB;

ANTIBODIES, MONOCLONAL; B7 ANTIGENS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; EPITOPES; FEMALE; HUMANS; INDOLES; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PYRROLES;

EID: 84892823050     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.10.038     Document Type: Article

References (39)

1. N. Howlader, A. Noone, M. Krapcho, N. Neyman, R. Aminou, and W. Waldron et al. SEER Cancer Statistics Review http://seer.cancer.gov/csr/1975-2008/ 1975-2008
2. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43
3. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
4. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, and K.Y. Look et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1996 1 6
5. C.N. Landen Jr., B. Goodman, A.A. Katre, A.D. Steg, A.M. Nick, and R.L. Stone et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol Cancer Ther 9 2010 3186 3199
6. P. Dalerba, R.W. Cho, and M.F. Clarke Cancer stem cells: models and concepts Annu Rev Med 58 2007 267 284
7. J.M. Rosen, and C.T. Jordan The increasing complexity of the cancer stem cell paradigm Science 324 2009 1670 1673
8. T. Baba, P.A. Convery, N. Matsumura, R.S. Whitaker, E. Kondoh, and T. Perry et al. Epigenetic regulation of CD133 and tumorigenicity of CD133 + ovarian cancer cells Oncogene 28 2009 209 218
9. D. Balicki Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1 Cell Stem Cell 1 2007 485 487
10. J.E. Carpentino, M.J. Hynes, H.D. Appelman, T. Zheng, D.A. Steindler, and E.W. Scott et al. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer Cancer Res 69 2009 8208 8215
11. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, and B. Esterni et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin Cancer Res 16 2010 45 55
12. M.D. Curley, V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, and A.M. Friel et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer Stem Cells 27 2009 2875 2883
13. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
14. S. Ma, K.W. Chan, L. Hu, T.K. Lee, J.Y. Wo, and I.O. Ng et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
15. S. Zhang, C. Balch, M.W. Chan, H.C. Lai, D. Matei, and J.M. Schilder et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68 2008 4311 4320
16. I. Kryczek, S. Liu, M. Roh, L. Vatan, W. Szeliga, and S. Wei et al. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells Int J Cancer 130 2012 29 39
17. W.K. Suh, B.U. Gajewska, H. Okada, M.A. Gronski, E.M. Bertram, and W. Dawicki et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nat Immunol 4 2003 899 906
18. M. Loos, D.M. Hedderich, H. Friess, and J. Kleeff B7-h3 and its role in antitumor immunity Clin Dev Immunol 2010 2010 683875
19. S.A. Boorjian, Y. Sheinin, P.L. Crispen, S.A. Farmer, C.M. Lohse, and S.M. Kuntz et al. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival Clin Cancer Res 14 2008 4800 4808
20. P.L. Crispen, Y. Sheinin, T.J. Roth, C.M. Lohse, S.M. Kuntz, and X. Frigola et al. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin Cancer Res 14 2008 5150 5157
21. J. Jiang, Y. Zhu, C. Wu, Y. Shen, W. Wei, and L. Chen et al. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer Cancer Immunol Immunother 59 2010 1707 1714
22. M. Loos, D.M. Hedderich, M. Ottenhausen, N.A. Giese, M. Laschinger, and I. Esposito et al. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer BMC Cancer 9 2009 463
23. J. Sun, L.J. Chen, G.B. Zhang, J.T. Jiang, M. Zhu, and Y. Tan et al. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma Cancer Immunol Immunother 59 2010 1163 1171
24. X. Zang, P.S. Sullivan, R.A. Soslow, R. Waitz, V.E. Reuter, and A. Wilton et al. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas Mod Pathol 23 2010 1104 1112
25. T.J. Roth, Y. Sheinin, C.M. Lohse, S.M. Kuntz, X. Frigola, and B.A. Inman et al. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res 67 2007 7893 7900
26. K.K. Zorn, T. Bonome, L. Gangi, G.V. Chandramouli, C.S. Awtrey, and G.J. Gardner et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer Clin Cancer Res 11 2005 6422 6430
27. Gynecologic Oncology Group http://www.gog.org [Accessed 10/8/2013]
28. K. Imai, B.S. Wilson, A. Bigotti, P.G. Natali, and S. Ferrone A 94,000-Dalton glycoprotein expressed by human melanoma and carcinoma cells J Natl Cancer Inst 68 1982 761 769
29. F. Perosa, and S. Ferrone Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies J Immunol 139 1987 1232 1239
30. Z. Duan, A.J. Feller, H.C. Toh, T. Makastorsis, and M.V. Seiden TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line Gene 229 1999 75 81
31. D.J. Buchsbaum, T. Zhou, W.E. Grizzle, P.G. Oliver, C.J. Hammond, and S. Zhang et al. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model Clin Cancer Res 9 2003 3731 3741
32. M.F. Clarke, J.E. Dick, P.B. Dirks, C.J. Eaves, C.H. Jamieson, and D.L. Jones et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339 9344
33. P. Dalerba, and M.F. Clarke Cancer stem cells and tumor metastasis: first steps into uncharted territory Cell Stem Cell 1 2007 241 242
34. C. Li, D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, and V. Adsay et al. Identification of pancreatic cancer stem cells Cancer Res 67 2007 1030 1037
35. N.A. Lobo, Y. Shimono, D. Qian, and M.F. Clarke The biology of cancer stem cells Annu Rev Cell Dev Biol 23 2007 675 699
36. M.E. Prince, R. Sivanandan, A. Kaczorowski, G.T. Wolf, M.J. Kaplan, and P. Dalerba et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
37. I.A. Silva, S. Bai, K. McLean, K. Yang, K.A. Griffith, and T. Dafydd et al. Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res 71 2011 3991 4001
38. C. Visus, D. Ito, A. Amoscato, M. Maciejewska-Franczak, A. Abdelsalem, and R. Dhir et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8 + T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck Cancer Res 67 2007 10538 10545
39. J.M. Fauci, J.M. Straughn Jr., S. Ferrone, and D.J. Buchsbaum A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer Gynecol Oncol 127 2012 420 425